Mary Chapman, features writer —

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

US company expands to Africa to speed SCD therapy development

To help bring new therapies more quickly and cost effectively to those with sickle cell disease (SCD) in sub-Saharan countries — where patients bear a significantly high SCD burden — the U.S.-based biotechnology company Functional Fluidics is planning to expand its operations into Africa. The expansion is expected…

New app for sickle cell disease helps patients manage pain

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. Called Pinpoint, the app is the product of a partnership between healthcare purchased services provider HPC…

Syros seeking new partner for its SCD program after Pfizer ends deal

Pfizer has decided to end a treatment discovery program with Syros Pharmaceuticals that it inherited after acquiring Global Blood Therapeutics (GBT) last year, leaving Syros to seek another partner for the program, which targets two blood disorders, including sickle cell disease (SCD). The agreement termination was announced…

Scribe, Sanofi expand research collaboration

Genetic medicines company Scribe Therapeutics has expanded its collaboration with Sanofi to advance the development of a new wave of in vivo treatments for sickle cell disease (SCD) and other disorders. The collaboration leverages Scribe’s proprietary CRISPR X-Editing technologies and Sanofi’s targeted non-viral delivery technologies for the…

SCDAA, MedicAlert working to improve emergency care

The Sickle Cell Disease Association of America (SCDAA) and the MedicAlert Foundation are partnering on a pilot program to help those living with sickle cell disease (SCD) receive faster and better emergency care. With the aim of improving the safety and well-being of patients during acute pain…

Nikkolas Smith portrait aims to boost blood donations for SCD

A digital portrait created by artist Nikkolas Smith for the American Red Cross seeks to heighten awareness of sickle cell disease (SCD) and the ongoing need for blood donations for SCD patients, particularly from Black donors. The artwork, titled “Transfusion,” depicts a young African American person crossing their hands,…

Supporters set to mark World Sickle Cell Day on June 19

With events ranging from a candlelight vigil to a new hospital exhibit to a 5K, supporters are poised to mark World Sickle Cell Day on June 19 to heighten awareness of the genetic blood disorder that affects millions of people internationally — and about 100,000 individuals in the U.S. In…

Free new app aims to help SCD patients and families manage care

Salveo Therapeutics and the newsmagazine African Sickle Cell News and World Report — known as Sickle Cell News — are collaborating to promote a new free application (app) that seeks to empower sickle cell disease (SCD) patients to take more control of their health and wellbeing. The overarching aim…

SCDAA, 8 pharma companies team up to increase trial participation

The Sickle Cell Disease Association of America (SCDAA) is collaborating with several pharmaceutical companies in a new initiative aimed at increasing awareness of the blood disorder and promoting clinical trial participation. Along with the SCDAA, the Sickle Cell Disease Collaboration of Advocates for Research, Education, and Science — officially…

Suburban Propane hopes to boost SCD awareness with blood drive

Suburban Propane Partners recently teamed up with the American Red Cross, its longtime national collaborator, to host a blood drive in Boston to boost sickle cell disease (SCD) awareness and encourage blood donations. The event was attended by Willie Gross, Boston’s former, and first, African American police commissioner. Some…